EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM
The review deals with the laboratory assessment of clopidogrel effect in patients with CHD. The article presents the results of major studies that have demonstrated the relationship between the residual platelet reactivity level and drug pharmacogenetics abnormalities causing coronary complications....
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«REMEDIUM GROUP» Ltd.
2015-12-01
|
Series: | Атеротромбоз |
Subjects: | |
Online Access: | https://www.aterotromboz.ru/jour/article/view/52 |
_version_ | 1797884011622694912 |
---|---|
author | A. L. Komarov |
author_facet | A. L. Komarov |
author_sort | A. L. Komarov |
collection | DOAJ |
description | The review deals with the laboratory assessment of clopidogrel effect in patients with CHD. The article presents the results of major studies that have demonstrated the relationship between the residual platelet reactivity level and drug pharmacogenetics abnormalities causing coronary complications. It discusses proposals of the international expert organizations on the assessment of sensitivity to clopidogrel and possible modifications of antiplatelet treatment. |
first_indexed | 2024-04-10T03:59:45Z |
format | Article |
id | doaj.art-b50675d4e7ef4d0c805e0bb42bfc12e7 |
institution | Directory Open Access Journal |
issn | 2307-1109 2658-5952 |
language | Russian |
last_indexed | 2024-04-10T03:59:45Z |
publishDate | 2015-12-01 |
publisher | «REMEDIUM GROUP» Ltd. |
record_format | Article |
series | Атеротромбоз |
spelling | doaj.art-b50675d4e7ef4d0c805e0bb42bfc12e72023-03-13T07:10:41Zrus«REMEDIUM GROUP» Ltd.Атеротромбоз2307-11092658-59522015-12-01029510610.21518/2307-1109-2015-2-95-10648EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEMA. L. Komarov0ФГБУ «Российский кардиологический научно-производственный комплекс» Министерства здравоохранения РФ, МоскваThe review deals with the laboratory assessment of clopidogrel effect in patients with CHD. The article presents the results of major studies that have demonstrated the relationship between the residual platelet reactivity level and drug pharmacogenetics abnormalities causing coronary complications. It discusses proposals of the international expert organizations on the assessment of sensitivity to clopidogrel and possible modifications of antiplatelet treatment.https://www.aterotromboz.ru/jour/article/view/52фармакогенетикаостаточная реактивность тромбоцитов к адфантиагрегантная терапиячрескожные коронарные вмешательстватромбоз |
spellingShingle | A. L. Komarov EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM Атеротромбоз фармакогенетика остаточная реактивность тромбоцитов к адф антиагрегантная терапия чрескожные коронарные вмешательства тромбоз |
title | EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM |
title_full | EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM |
title_fullStr | EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM |
title_full_unstemmed | EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM |
title_short | EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM |
title_sort | evaluation of sensitivity to clopidogrel the current state of the problem |
topic | фармакогенетика остаточная реактивность тромбоцитов к адф антиагрегантная терапия чрескожные коронарные вмешательства тромбоз |
url | https://www.aterotromboz.ru/jour/article/view/52 |
work_keys_str_mv | AT alkomarov evaluationofsensitivitytoclopidogrelthecurrentstateoftheproblem |